[HTML][HTML] Innate and adaptive immune responses against coronavirus

A Hosseini, V Hashemi, N Shomali, F Asghari… - Biomedicine & …, 2020 - Elsevier
Coronaviruses (CoVs) are a member of the Coronaviridae family with positive‐sense single-
stranded RNA. In recent years, the CoVs have become a global problem to public health …

Potential effects of curcumin in the treatment of COVID‐19 infection

F Zahedipour, SA Hosseini, T Sathyapalan… - Phytotherapy …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) outbreak is an ongoing pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with considerable …

Coronavirus disease 2019 (COVID-19) in children: prevalence, diagnosis, clinical symptoms, and treatment

H Zare-Zardini, H Soltaninejad… - … journal of general …, 2020 - Taylor & Francis
In this article, we have reviewed the prevalence, diagnosis, symptoms, and treatment of
COVID-19 in children. The incidence of COVID-19 among children under 18 years was 2.1 …

[HTML][HTML] Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach

MS Rahman, MN Hoque, MR Islam, S Akter… - PeerJ, 2020 - peerj.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the
ongoing pandemic of coronavirus disease 2019 (COVID-19), a public health emergency of …

Administration of COVID-19 vaccines in immunocompromised patients

M Negahdaripour, M Shafiekhani, SMI Moezzi… - International …, 2021 - Elsevier
Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences

M Lotfi, N Rezaei - Journal of medical virology, 2020 - Wiley Online Library
Nowadays, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which caused
novel coronavirus disease (COVID‐19) pandemic, is the worldwide challenge. The virus is …

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico …

A Rakib, Z Nain, SA Sami, S Mahmud… - Briefings in …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global …

Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID‐19 prevention and cure

MN Islam, KS Hossain, PP Sarker… - Phytotherapy …, 2021 - Wiley Online Library
Nigella sativa seed and its active compounds have been historically recognized as an
effective herbal panacea that can establish a balanced inflammatory response by …

Immunotherapeutic approaches to curtail COVID-19

H Owji, M Negahdaripour, N Hajighahramani - International …, 2020 - Elsevier
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …